Zogenix, Inc. (NASDAQ:ZGNX)

Thursday’s Top 4 Biotech Movers

Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff. Although the sector is feeling the pinch from the ...
Read Full Story »

Bad News for Epilepsy Seizure Patients Following FDA Update

Zogenix Inc. (NASDAQ: ZGNX) shares were crushed on Tuesday after the firm provided an update from the U.S. Food and Drug Administration (FDA). Unfortunately, the agency sent a Refusal to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Caterpillar, Costco, GW Pharma, NXP, Southwest Air, Teva, Ulta, Wells Fargo and More

Stocks were indicated marginally lower after a strong jobs numbers on Friday morning, but despite a sell-off, the market remains close to all-time highs. Investors have seen less upside when ...
Read Full Story »

How Zogenix Is Winning Big With Late-Stage Seizure Study

Zogenix Inc. (NASDAQ: ZGNX) shares made a solid gain on Thursday after the company announced positive results from its late-stage seizure trial. Essentially, the company reported positive top-line results from ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AECOM, Ciena, Evoqua Water Tech, Funko, GlaxoSmithKline, Square and Many More

Stocks were directionless on Monday, with most Americans slowly trickling back into the office after an extended Thanksgiving break. Still, the major U.S. indexes remain close to all-time highs and ...
Read Full Story »

Why Zogenix Shares More Than Doubled

Zogenix Inc. (NASDAQ: ZGNX) saw its shares more than double early on Friday after the company reported positive top-line results from its most recent late-stage trial in the treatment of ...
Read Full Story »
white pills

Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas

We have written at length on the beating the biotechs have endured. Another sub-sector that has been right alongside for the trip to the Wall Street woodshed has been specialty ...
Read Full Story »
Money and plant

4 Analyst Stock Picks With 50% to 100% Upside Potential

As we head into a huge stretch of earnings, many investors are wondering if a fourth-quarter rally is really in the cards, or whether we will start hitting lower higher ...
Read Full Story »
179378515

5 Highly Unusual Stock Moves of the Past Week

The bull market may have seen an interruption this past week, but stocks are still very close to all-time highs and this bull market is now six years old. It ...
Read Full Story »
biotech

The Gamble That Did Not Pay Off

Zogenix Inc. (NASDAQ: ZGNX) announced an agreement for the sale of its Zohydro ER (hydrocodone bitartrate) business to Pernix for $100 million. This transaction will be composed of $30 million ...
Read Full Story »
ten dollars

8 Analyst Stocks Under $10 With Major Upside Calls

Volatility is back, with two weeks in a row of big sell-offs followed by big gains. What this means is that investors and traders remain more than eager to find stocks ...
Read Full Story »
health care

Analyst Still Sees Zogenix Potentially Doubling

Zogenix Inc. (NASDAQ: ZGNX) has been a controversial small cap drug stock, with its abuse-deterrent Zohydro being at front and center. Now that the company has submitted its supplemental new ...
Read Full Story »
Pills

Zogenix CEO Goes on the Offensive

Zogenix Inc. (NASDAQ: ZGNX) has traded like a company that is about to implode. Its highly controversial Zohydro has been getting inquiries into how it was approved for marketing despite ...
Read Full Story »
biotech

Zogenix Tumbles on Fears Its Pain Drug May Lose Out to a Rival

Shares of Zogenix Inc. (NASDAQ: ZGNX) fell as much as 26% on Wednesday after a rival pharmaceutical company said it will seek regulatory approval of a tamper-proof version of Zogenix's ...
Read Full Story »
biotech

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

The Leerink Global Healthcare conference is in full swing, and the reports coming out highlight what some top analysts on Wall Street already suspected. The rich are getting richer. With ...
Read Full Story »